Sioban B Keel MD
Assistant Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-228-1000
Dr. Keel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2002 - 2006
University of MinnesotaResidency, Internal Medicine, 1999 - 2002- University of Minnesota Medical SchoolClass of 1999
Certifications & Licensure
WA State Medical License 2002 - 2025
MN State Medical License 2003 - 2004
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.Peter L Greenberg, Richard M Stone, Yasmin Abaza, Aref Al-Kali, Sarah Anand
Journal of the National Comprehensive Cancer Network. 2025-03-01 - Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in-familial platelet disorder.Mona Mohammadhosseini, Trevor Enright, Adam Duvall, Alex Chitsazan, Hsin-Yun Lin
Science Translational Medicine. 2025-01-08 - Liver disease and transplantation in telomere biology disorders: An international multicenter cohort.YunZu Michele Wang, Batul Kaj-Carbaidwala, Adam Lane, Suneet Agarwal, Fabian Beier
Hepatology Communications. 2024-07-01
Abstracts/Posters
- Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myel...Sioban B. Keel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparative Analysis of Patterns of Infectious Complications of Outpatient Vs. Inpatient Care Following Intensive Induction Chemotherapy for Adults with Acute Myeloid ...Sioban Keel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...Sioban B. Keel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
